Latest Breaking News On - Michel khouri - Page 1 : vimarsana.com

BridgeBio Pharma : BBIO – Acoramidis AG10 TTR – ISA 2024 – Higher risk of mortality in previously hospitalized patients

Higher Risk of Mortality in Previously Hospitalized Patients: Insights From ATTRibute-CM Ahmad Masri1, Michele Emdin2, Keyur Shah3, Kunal Bhatt4,.

United statesSan franciscoPalo altoWestern australiaStanford universityDariusz korczykKunal bhattMichel khouriKevin alexanderJonathanc foxNoel dasguptaAhmad masriMichele emdinMartha groganMichael johnstoneSuresh siddhanti

BridgeBio Pharma to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the 2024 ISA Meeting

BridgeBio Pharma to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the 2024 ISA Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBritish columbiaJean francois tambyKevinm alexanderMargot davisJuliand gillmoreBrettw sperryVikram baliMichel khouriMathew maurerAhmad masriJohn whangNitasha sarswatMazen hannaPablo garcia pavia